Medical management chronic heart failure inotropic vasodilator inodilator drugs basis pathophysiologic mechanisms medical therapy today chronic heart failure advantages disadvantages vasodilator drugs inotropic drugs therapeutic value inodilator drugs central myocardial effects positive inotropic agents peripheral vasodilators particular available dopaminergic agents ibopamine beta-receptors heart positive inotropic effect dopaminergic receptors peripheral vessels systemic vasodilator effect kidneys natriuretic effect diuresis advancement modern medical therapy chronic heart failure Data long-term treatment ibopamine sustained clinical benefit heart failure decrease adrenergic receptors blood cells Dopamine plasma concentration long-term treatment discrepancy clinical improvement adrenergic downregulation due interference inodilator neurohormonal systems multiple sites independent receptor activation biosynthesis noradrenaline intracellular dopamine transport 